It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Hip fractures are a leading cause of death and disability among older adults. Hip fractures are also the most commonly missed diagnosis on pelvic radiographs, and delayed diagnosis leads to higher cost and worse outcomes. Computer-aided diagnosis (CAD) algorithms have shown promise for helping radiologists detect fractures, but the image features underpinning their predictions are notoriously difficult to understand. In this study, we trained deep-learning models on 17,587 radiographs to classify fracture, 5 patient traits, and 14 hospital process variables. All 20 variables could be individually predicted from a radiograph, with the best performances on scanner model (AUC = 1.00), scanner brand (AUC = 0.98), and whether the order was marked “priority” (AUC = 0.79). Fracture was predicted moderately well from the image (AUC = 0.78) and better when combining image features with patient data (AUC = 0.86, DeLong paired AUC comparison, p = 2e-9) or patient data plus hospital process features (AUC = 0.91, p = 1e-21). Fracture prediction on a test set that balanced fracture risk across patient variables was significantly lower than a random test set (AUC = 0.67, DeLong unpaired AUC comparison, p = 0.003); and on a test set with fracture risk balanced across patient and hospital process variables, the model performed randomly (AUC = 0.52, 95% CI 0.46–0.58), indicating that these variables were the main source of the model’s fracture predictions. A single model that directly combines image features, patient, and hospital process data outperforms a Naive Bayes ensemble of an image-only model prediction, patient, and hospital process data. If CAD algorithms are inexplicably leveraging patient and process variables in their predictions, it is unclear how radiologists should interpret their predictions in the context of other known patient data. Further research is needed to illuminate deep-learning decision processes so that computers and clinicians can effectively cooperate.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Verily Life Sciences LLC, South San Francisco, USA; Icahn School of Medicine at Mount Sinai, Institute for Next Generation Healthcare, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
2 California Pacific Medical Center, Department of Medicine, San Francisco, USA (GRID:grid.17866.3e) (ISNI:0000000098234542)
3 The University of Adelaide, School of Public Health, Adelaide, Australia (GRID:grid.1010.0) (ISNI:0000 0004 1936 7304)
4 University of California, Bakar Computational Health Sciences Institute, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
5 Verily Life Sciences LLC, South San Francisco, USA (GRID:grid.266102.1)
6 The University of Adelaide, School of Computer Sciences, Adelaide, Australia (GRID:grid.1010.0) (ISNI:0000 0004 1936 7304)
7 Verily Life Sciences LLC, South San Francisco, USA (GRID:grid.1010.0); Stanford School of Medicine, Division of Cardiovascular Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
8 Icahn School of Medicine at Mount Sinai, Institute for Next Generation Healthcare, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
9 Verily Life Sciences LLC, South San Francisco, USA (GRID:grid.59734.3c)
10 Icahn School of Medicine at Mount Sinai, Institute for Next Generation Healthcare, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)